Michael James Morrissey's Insider Trades & SAST Disclosures
Michael James Morrissey's most recent trade in Incyte Corp. was a trade of 10,552 Common Stock done . Disclosure was reported to the exchange on Jan. 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael James Morrissey.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 10,552 | 81,515 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.47 per share. | 21 Jan 2025 | 429 | 70,963 (0%) | 0% | 73.5 | 31,519 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.46 per share. | 15 Jan 2025 | 908 | 71,392 (0%) | 0% | 72.5 | 65,794 | Common Stock |
| Incyte Corp. | Morrissey Michael James | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.50 per share. | 22 Jan 2024 | 108 | 72,300 (0%) | 0% | 61.5 | 6,642 | Common Stock |
| Incyte Corp. | James Morrissey Michael | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 61.18 per share. | 18 Jan 2024 | 11,359 | 72,530 (0%) | 0% | 61.2 | 694,944 | Common Stock |
| Incyte Corp. | Michael Morrissey James | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.49 per share. | 18 Jan 2024 | 122 | 72,408 (0%) | 0% | 61.5 | 7,502 | Common Stock |
| Incyte Corp. | Morrissey Michael James | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.48 per share. | 16 Jan 2024 | 101 | 61,171 (0%) | 0% | 61.5 | 6,209 | Common Stock |
| Incyte Corp. | Morrissey James Michael | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.34 per share. | 16 Jan 2024 | 101 | 61,272 (0%) | 0% | 61.3 | 6,195 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 6,159 | 61,373 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.88 per share. | 19 Jan 2023 | 105 | 55,214 (0%) | 0% | 83.9 | 8,807 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.26 per share. | 15 Jan 2023 | 87 | 55,319 (0%) | 0% | 81.3 | 7,070 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.26 per share. | 15 Jan 2023 | 87 | 55,406 (0%) | 0% | 81.3 | 7,070 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.08 per share. | 04 Jan 2023 | 117 | 55,493 (0%) | 0% | 79.1 | 9,252 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.35 per share. | 24 Jan 2022 | 78 | 55,610 (0%) | 0% | 75.3 | 5,877 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 6,959 | 55,688 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.01 per share. | 18 Jan 2022 | 101 | 48,830 (0%) | 0% | 75.0 | 7,576 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.01 per share. | 18 Jan 2022 | 101 | 48,729 (0%) | 0% | 75.0 | 7,576 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.81 per share. | 04 Jan 2022 | 136 | 48,931 (0%) | 0% | 71.8 | 9,766 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 3,615 | 49,067 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Sale of securities on an exchange or to another person at price $ 81.08 per share. | 29 Mar 2021 | 20,000 | 45,452 (0%) | 0% | 81.1 | 1,621,600 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.50 per share. | 25 Jan 2021 | 78 | 65,452 (0%) | 0% | 100.5 | 7,839 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 11,522 | 59,943 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 5,761 | 65,704 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.96 per share. | 15 Jan 2021 | 174 | 65,530 (0%) | 0% | 94.0 | 16,349 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.45 per share. | 04 Jan 2021 | 136 | 48,421 (0%) | 0% | 86.4 | 11,757 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges